Management paradigms for chronic rhinosinusitis in individuals with asthma: An evidence‐based review with recommendations
International Forum of Allergy & Rhinology · 2023
DOI: 10.1002/alr.23130 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Forum of Allergy & Rhinology, 2023. Verfasst von Amarbir S Gill und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Rhinitis, Sinusitis, Asthma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 122 Literaturangaben.
Abstract (Originalsprache)
Background
Despite the significant morbidity associated with chronic rhinosinusitis (CRS) in individuals with asthma (CRSwA), there is a paucity of codified, evidence‐based management strategies for CRS in this population.
Methods
Using PubMed, Embase, and Cochrane Review Databases, a systematic review was performed covering management strategies for CRSwA. A total of 5903 articles were screened, and 70 were included for full‐text analysis. After application of exclusion criteria, 53 articles comprised the qualitative synthesis. The level of evidence was graded and benefit‐harm assessments, as well as value judgment and recommendations, were provided Results Strong evidence confirms the benefit of oral and topical medications on sinonasal‐specific outcomes in individuals with CRSwA; there is low‐grade evidence demonstrating that these agents improve lung function and/or asthma control. Moderate to strong evidence suggests that endoscopic sinus surgery (ESS) improves both sinonasal‐ and asthma‐specific quality of life. Although there is insufficient to low evidence to indicate that ESS improves pulmonary function in this population, data indicate a positive impact of this intervention on asthma control. Biologic medications strongly improve both subjective and objective sinonasal‐ and asthma‐specific outcomes.
Conclusion
Evidence supports managing CRS in individuals with CRSwA in a stepwise fashion, starting with traditional nonbiologic oral and topical medication, and escalating to second‐line treatments, such as ESS and biologics. Optimal treatment of individuals who have CRSwA often requires concurrent, directed management of asthma, as not all CRS interventions impact asthma status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA.
- Division of Otolaryngology - Head and Neck Surgery, Department of Surgery, University of Utah, Salt Lake City, Utah, USA.
- Division of Rhinology and Sinus Surgery/Oregon Sinus Center, Department of Otolaryngology-Head and Neck Surgery, Oregon Health & Science University, Portland, Oregon, USA.
- Department of Otolaryngology-Head and neck Surgery, Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Otolaryngology - Head and Neck Surgery, Harvard Medical School, Department of Otolaryngology - Head and Neck Surgery, Massachusetts Eye and Ear, Boston, Massachusetts, USA.
- Department of Otorhinolaryngology, University Hospitals Leuven, and Department of Otorhinolaryngology, Upper Airway Research Laboratory, University of Ghent, Ghent, Belgium.
ORCID-Profile: Amarbir S Gill, Jeremiah A Alt, Nicholas R Rowan, Daniel M Beswick
Zitieren
APA
Gill, A. S., Alt, J. A., Detwiller, K. Y., Rowan, N. R., Gray, S. T., Hellings, P. W., Joshi, S. R., Lee, J. T., Soler, Z. M., Tan, B. K., Taylor-Cousar, J. L., Wise, S. K., Wu, T. J., & Beswick, D. M. (2023). Management paradigms for chronic rhinosinusitis in individuals with asthma: An evidence‐based review with recommendations. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.23130
Vancouver
Gill AS, Alt JA, Detwiller KY, Rowan NR, Gray ST, Hellings PW, et al. Management paradigms for chronic rhinosinusitis in individuals with asthma: An evidence‐based review with recommendations. International Forum of Allergy & Rhinology. 2023. doi:10.1002/alr.23130
BibTeX
@article{Gill2023,
author = {Gill, Amarbir S and Alt, Jeremiah A and Detwiller, Kara Y and Rowan, Nicholas R and Gray, Stacey T and Hellings, Peter W and Joshi, Shyam R and Lee, Jivianne T and Soler, Zach M and Tan, Bruce K and Taylor-Cousar, Jennifer L and Wise, Sarah K and Wu, Tara J and Beswick, Daniel M},
title = {Management paradigms for chronic rhinosinusitis in individuals with asthma: An evidence‐based review with recommendations},
journal = {International Forum of Allergy & Rhinology},
year = {2023},
doi = {10.1002/alr.23130}
}
EUVIMED